ProKidney’s cell therapy for kidney disease failed to demonstrate a clinically significant preservation of kidney function in one part of a phase 2 study, but the biotech has pointed to the trial’s ...

Shares of Soligenix rallied sharply on Tuesday, marking their best performance in nearly two months, after the biopharmaceutical company reported a key safety milestone in its confirmatory Phase 3 ...

Cell C is giving South Africans 10 million reasons to stay connected with the return of its thrilling Win Big campaign – amplified! Why settle for small wins when you can have amplified ones? Cell C ...